Warning: Last items in stock!
Afanix（GILOTRIF）is a kinase inhibitor indicated for:
1.First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test.
Limitation of Use: Safety and efficacy of GILOTRIF were not established in patients whose tumors have resistant EGFR mutations
2.Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy
DOSAGE AND ADMINISTRATION
1.Recommended dose: 40 mg orally, once daily
2.Renal impairment: 30 mg orally, once daily in patients with severe renal impairment
3.Instruct patients to take GILOTRIF at least 1 hour before or 2 hours after a meal
Afanix’s brand name is GILOTRIF® by Boehringer Ingelheim. Afanix is a generic oncologic prescription medicine from Beacon, which is the biggest pharmaceutical company in Bangladesh.
For more Prescribing information，please check the → “FDA Prescribing Information”.
|Warnings||Don't take the drug without consulting a qualified doctor or physician|
|Suggested use||Follow the doctor's advice|
|Delivery & Returns||7-14 Days|
GILOTRIF® (Afatinib) 40mg